三星医疗收盘下跌1.99%，滚动市盈率12.85倍，总市值306.33亿元

Core Viewpoint - Samsung Medical's stock closed at 21.71 yuan, down 1.99%, with a rolling PE ratio of 12.85 times, significantly lower than the industry average of 35.02 times [1][2] Company Overview - Samsung Medical's main business segments include smart power distribution and medical services, with key products such as smart meters, high-end gateway meters, and various energy solutions [1] - The company has received multiple accolades, including being recognized as a national-level intellectual property demonstration enterprise and a provincial key enterprise research institute [1] Financial Performance - For Q1 2025, Samsung Medical reported revenue of 36.31 billion yuan, a year-on-year increase of 20.03%, and a net profit of 4.89 billion yuan, up 34.33% [2] - The company's gross profit margin stands at 28.90% [2] Market Position - Samsung Medical ranks 36th in the electric grid equipment industry based on PE ratio, with a total market capitalization of 306.33 billion yuan [1][2] - The company is held by 101 institutions, including 99 funds, with a total shareholding of 61,407.10 million shares valued at 181.58 billion yuan [1]